I'll take a stab at that. There will be no retail sellers or institutional sellers tomorrow, and the only possible sellers will be shorts trying to stem any momemtum. On the other hand, buyers will be timid to chase the stock because of the fear of a delay by an additional phase II trial to determine the required endocrine endpoints...
I plan to be a buyer all the way to $12 and I do not plan to sell any before $15. My thinking is that the stock will end the day tomorrow somewhere in the $13's but it may start the day at much more modest levels. One month from now I see RPRX trading north of $15...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.